Salesforce
CRM
Apple
AAPL
Cisco
CSCO
Advanced Micro Devices
AMD
Alibaba
BABA
US Stock MarketDetailed Quotes
PTIX Protagenic Therapeutics
- 0.5150
- -0.0052-1.00%
Trading Dec 12 14:59 ET
3.50MMarket Cap-0.41P/E (TTM)
0.5488High0.5070Low29.36KVolume0.5320Open0.5202Pre Close15.15KTurnover0.50%Turnover RatioLossP/E (Static)6.79MShares1.870052wk High4.86P/B3.00MFloat Cap0.451552wk Low--Dividend TTM5.82MShs Float19.5600Historical High--Div YieldTTM8.04%Amplitude0.4515Historical Low0.5150Avg Price1Lot Size
Protagenic Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -79.98%1.06M | -84.70%924.6K | -68.32%2.42M | -49.16%4.06M | -49.16%4.06M | -35.33%5.27M | -31.86%6.04M | -21.82%7.65M | -23.07%7.98M | -23.07%7.98M |
| -Cash and cash equivalents | 588.57%1.06M | 321.35%924.6K | 500.60%831.78K | 498.49%1.29M | 498.49%1.29M | -3.15%153.33K | -35.21%219.44K | -71.28%138.49K | -60.24%215.19K | -60.24%215.19K |
| -Short-term investments | --0 | --0 | -78.81%1.59M | -64.34%2.77M | -64.34%2.77M | -35.96%5.12M | -31.73%5.82M | -19.25%7.51M | -21.02%7.76M | -21.02%7.76M |
| Prepaid assets | 252.53%366.9K | -49.20%444.29K | 213.82%43.99K | 152.95%144.03K | 152.95%144.03K | 2.45%104.08K | 498.16%874.67K | 8.53%14.02K | -91.73%56.94K | -91.73%56.94K |
| Total current assets | -73.54%1.42M | -80.21%1.37M | -67.80%2.47M | -47.73%4.2M | -47.73%4.2M | -34.86%5.38M | -23.26%6.92M | -21.78%7.66M | -27.34%8.04M | -27.34%8.04M |
| Non current assets | ||||||||||
| Net PPE | 52.94%85.62K | 6,056.05%98.19K | 6,473.35%110.76K | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K | --1.78K | --1.78K |
| Total non current assets | 52.94%85.62K | 6,056.05%98.19K | 6,473.35%110.76K | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K | --1.78K | --1.78K |
| Total assets | -72.24%1.51M | -78.80%1.47M | -66.36%2.58M | -46.21%4.32M | -46.21%4.32M | -34.18%5.43M | -23.24%6.92M | -21.76%7.67M | -27.33%8.04M | -27.33%8.04M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -55.39%108.64K | -40.91%93.46K | -37.70%108.95K | -26.81%113.8K | -26.81%113.8K | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K | -44.26%155.49K | -44.26%155.49K |
| -accounts payable | -55.39%108.64K | -40.91%93.46K | -37.70%108.95K | -26.81%113.8K | -26.81%113.8K | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K | -44.26%155.49K | -44.26%155.49K |
| Current accrued expenses | 10.35%680.69K | -39.02%581.1K | -52.38%337.15K | -12.69%541.45K | -12.69%541.45K | 48.94%616.82K | 639.89%952.91K | 40.37%707.97K | 19.13%620.15K | 19.13%620.15K |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | --419.76K | --394.31K | --369.13K | --344.23K | --344.23K |
| -Current debt | ---- | ---- | ---- | ---- | ---- | --419.76K | --394.31K | --369.13K | --344.23K | --344.23K |
| Current liabilities | -38.34%789.32K | -55.19%674.56K | -64.37%446.1K | -41.49%655.25K | -41.49%655.25K | 131.28%1.28M | 225.08%1.51M | 59.76%1.25M | 40.06%1.12M | 40.06%1.12M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -38.34%789.32K | -55.19%674.56K | -64.37%446.1K | -41.49%655.25K | -41.49%655.25K | 46.76%1.28M | 99.02%1.51M | 16.06%1.25M | 0.17%1.12M | 0.17%1.12M |
| Shareholders'equity | ||||||||||
| Share capital | 10.83%481 | 3.00%447 | 2.30%444 | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 | 0.46%434 | 0.46%434 |
| -common stock | 10.83%481 | 3.00%447 | 2.30%444 | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 | 0.46%434 | 0.46%434 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -19.41%-34.75M | -23.11%-34.11M | -22.67%-32.5M | -19.40%-30.78M | -19.40%-30.78M | -15.59%-29.1M | -14.24%-27.71M | -12.35%-26.5M | -16.00%-25.78M | -16.00%-25.78M |
| Paid-in capital | 5.10%35.6M | 3.93%35.03M | 3.53%34.72M | 3.56%34.56M | 3.56%34.56M | 2.11%33.87M | 2.27%33.7M | 2.56%33.54M | 2.96%33.37M | 2.96%33.37M |
| Gains losses not affecting retained earnings | 78.92%-130.25K | 77.81%-130.16K | 86.20%-86.77K | 83.23%-113.55K | 83.23%-113.55K | -0.43%-617.74K | -30.42%-586.46K | -57.44%-628.76K | -172.56%-676.91K | -172.56%-676.91K |
| Total stockholders'equity | -82.69%719.01K | -85.36%792.52K | -66.75%2.13M | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M | -30.42%6.92M | -30.42%6.92M |
| Total equity | -82.69%719.01K | -85.36%792.52K | -66.75%2.13M | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M | -30.42%6.92M | -30.42%6.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.